Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,6 Month Schedule

Clinical trial NCT00289744 · COMPLETED

Trial details

NCT number: NCT00289744
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hepatitis B Hepatitis A

Start date: 2004-02-16
Primary completion: 2009-04-15
Enrollment: 178

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.